IL33 and autoimmune disease: Serum IL-33 and sST2 have been associated with more severe autoimmune diseases (i.e., Sjögren’s disease, myocarditis), asthma, and cancers, but use of knockout mice and recombinant protein or blocking antibody in animal models have yielded conflicting results (13–15).